UGT2B28 genomic variation is associated with hepatitis B e-antigen seroconversion in response to antiviral therapy.
about
UGT2B28 genomic variation is associated with hepatitis B e-antigen seroconversion in response to antiviral therapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 September 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
UGT2B28 genomic variation is a ...... response to antiviral therapy.
@en
UGT2B28 genomic variation is a ...... response to antiviral therapy.
@nl
type
label
UGT2B28 genomic variation is a ...... response to antiviral therapy.
@en
UGT2B28 genomic variation is a ...... response to antiviral therapy.
@nl
prefLabel
UGT2B28 genomic variation is a ...... response to antiviral therapy.
@en
UGT2B28 genomic variation is a ...... response to antiviral therapy.
@nl
P2093
P2860
P356
P1433
P1476
UGT2B28 genomic variation is a ...... response to antiviral therapy.
@en
P2093
Chao-Wei Hsu
Chau-Ting Yeh
Chih-Lang Lin
Kung-Hao Liang
Ming-Wei Lai
Rong-Nan Chien
P2860
P2888
P356
10.1038/SREP34088
P407
P577
2016-09-26T00:00:00Z